Tuberculosis (TB) is a rare cause of chylothorax. We describe a case and the results of a systematic review of all reported cases of TB-chylothorax. We identified 37 cases of TB-chylothorax. The symptoms at presentation were constitutional (85.7%; 30/35), dyspnea (60.6%; 20/33), and cough (54.5%; 18/33). Chylothorax developed subsequent to the diagnosis of TB in 27.8% (10/36) of the patients, after a median of 6.75 weeks (IQR 4–9). Chylothorax developed during an immune reconstitution syndrome (IRS) in 16.7% (10/36) of the patients, including immunocompetent ones. TB was disseminated in 45.9% (17/37) of the patients at the diagnosis of chylothorax. Chylothorax developed in the absence of any mediastinal lymphadenopathy in 45.9% (17/37) of the patients; 13.5% (5/37) had isolated tubercular empyema alone. The diagnosis of TB was established microbiologically in 72.2% (26/36) and by biopsy alone in 27.8% (9/36) of the patients. Anti-TB treatment (ATT) was administered for a median of 7.57 months (IQR 6–9). Steroids were administered to 22.9% (8/35) of the patients, often for suspected IRS. Thoracic duct ligation and octreotide were required for only 17.1% (6/35) and 8.6% (3/35) of the patients, respectively. In all, 94.4% (34/36) of the patients had resolution of chylothorax and completed treatment successfully; only 5.6% (2/36) died. In conclusion, TB-chylothorax may develop without obvious mediastinal lymphadenopathy and be associated with tubercular empyema alone. TB-chylothorax can develop during treatment of TB due to IRS, even in immunocompetent patients. ATT and dietary manipulation are associated with good resolution and low mortality, and duct ligation is needed for only a small minority of patients.

Keywords:
Tuberculosis, Chylothorax, Pleural effusion, Chylomicron
1.
Arinaminpathy N, Batra D, Khaparde S, Vualnam T, Maheshwari N, Sharma L, Nair SA, Dewan P: The number of privately treated tuberculosis cases in India: an estimation from drug sales data. Lancet Infect Dis 2016; 16: 1255–1260.
2.
WHO: Global Tuberculosis Report 2016. 2016. http://apps.who.int/medicinedocs/documents/s23098en/s23098en.pdf.
3.
Hillerdal G: Chylothorax and pseudochylothorax. Eur Respir J 1997; 10: 1157–1162.
4.
Romero S: Nontraumatic chylothorax. Curr Opin Pulm Med 2000; 6: 287–291.
5.
Ferrer J: Pleural tuberculosis. Eur Respir J 1997; 10: 942–947.
6.
Vennera MC, Moreno R, Cot J, Marin A, Sanchez-Lloret J, Picado C, Agusti-Vidal A: Chylothorax and tuberculosis. Thorax 1983; 38: 694–695.
7.
Zafar A, Gul M, Zaman R: Chylothorax. J Ayub Med Coll Abbottabad 1988; 3: 27–28.
8.
Menzies R, Hidvegi R: Chylothorax associated with tuberculous spondylitis. Can Assoc Radiol J 1988; 39: 238–241.
9.
Haro M, Ruiz J, Álvarez J, Gallego M: Quilotórax tuberculoso. Enferm Infecc Microbiol Clin 1994; 12: 417–418.
10.
Antón PA, Rubio J, Casán P, Franquet T: Chylothorax due to Mycobacterium tuberculosis. Thorax 1995; 50: 1019.
11.
Deniel F, Rabbat A, Laaban JP: Spontaneous bilateral chylothorax revealing disseminated tuberculosis complicated by massive pulmonary embolism (in French). Rev Mal Respir 1999; 16: 836–838.
12.
Singh S, Girod JP, Ghobrial MW: Chylothorax as a complication of tuberculosis in the setting of the human immunodeficiency virus infection. Arch Intern Med 2001; 161: 2621.
13.
Prasad RS, Fraser MH, Urquhart GD, McLean AN: Rupture of tuberculous spinal abscess resulting in tuberculous empyema and chylothorax. Spinal Cord 2003; 41: 410–412.
14.
Tomić I, Plavec G, Karlicić V, Spasić V, Rusović S, Stanić V, Cvijanović V, Ristanović A: Chylous effusions (in Serbian). Vojnosanit Pregl 2003; 60: 613–620.
15.
Gie RP, Goussard P, Kling S, Schaaf HS, Beyers N: Unusual forms of intrathoracic tuberculosis in children and their management. Paediatr Respir Rev 2004; 5(suppl A):S139–S141.
16.
Gupta D, Maheshwari U, Aggarwal AN: Tuberculosis chylothorax. Lung India 2004; 21: 54–55.
17.
Chen HA, Cheng NC, Lin KP, Liao HT, Chen CH, Huang DF: Mononeuropathy multiplex and chylothorax as earlier manifestations of pulmonary tuberculosis. J Intern Med 2005; 257: 561–563.
18.
Saumoy M, Mirón M, Oltra C, Vidal F, Ri-chart C: Tuberculous chylothorax: case report and review of the literature (in Spanish). An Med Interna 2005; 22: 238–240.
19.
Singh P, Shah KV, Shah NT, Chauhan JB, Shah B, Jindal S, Gami S: Chylothorax: a rare presentation of constrictive pericarditis. Indian J Tuberc 2005; 52: 207–210.
20.
Baig F, Khan SG, Warind J: Tuberculous chylothorax. Chest DOI: 10.1378/chest.130.4_MeetingAbstracts.304S-a.
21.
Büyükşirin M, Konya A, Polat G, Ürpek G, Tibet G: Case of chylothorax due to Mycobacterium tuberculosis. Toraks Dergisi 2006; 7: 216–217.
22.
Cakir E, Gocmen B, Uyan ZS, Oktem S, Kiyan G, Karakoc F, Ersu R, Karadag B, Dagli T, Dagli E: An unusual case of chylothorax complicating childhood tuberculosis. Pediatr Pulmonol 2008; 43: 611–614.
23.
Grobbelaar M, Andronikou S, Goussard P, Theron S, Mapukata A, George R: Chylothorax as a complication of pulmonary tuberculosis in children. Pediatr Radiol 2008; 38: 224–226.
24.
Karapolat S, Sanli A, Onen A: Chylothorax due to tuberculosis lymphadenopathy: report of a case. Surg Today 2008; 38: 938–941.
25.
Lin JN, Lai CH, Chen YH, Chang LL, Lee SS, Lin HH: Immune reconstitution inflammatory syndrome presenting as chylothorax in a patient with HIV and Mycobacterium tuberculosis coinfection: a case report. BMC Infect Dis 2010; 10: 321.
26.
Rabie H, Lomp A, Goussard P, Nel E, Cotton M: Paradoxical tuberculosis associated immune reconstitution inflammatory syndrome presenting with chylous ascites and chylothorax in a HIV-1 infected child. J Trop Pediatr 2010; 56: 355–358.
27.
Hijazi EM, Hamouri S: Post-coronary artery bypass grafting chylothorax with tuberculous empyema thoracis. Am J Case Rep 2011; 12: 184–185.
28.
Kant S, Verma SK, Anand SC, Prasad R, Verma RK: Development of bilateral chylothorax in a younger female secondary to tuberculosis. Lung India 2011; 28: 56–59.
29.
Ananthan VS, Siva KK: A rare case of acid-fast bacilli in chylothorax. Lung India 2012; 29: 166–168.
30.
Tan GP, Tai DYH, Nallakaruppan VDO: A case of chylothorax. Chest DOI: 10.1378/chest.1383008.
31.
Yasaratne BMGD, Madegedara RMD: Chylothorax; a description of four cases and a brief review. J Ceylon Coll Phys 2012; 43: 49–53.
32.
Ip H, Schomberg LE, Ahmed L: Pleural effusions in a patient with tuberculosis on dialysis. Lancet 2013; 382: 570.
33.
Bielsa S, Pardina M, Porcel JM: Chylothorax due to enlarged tuberculous lymph nodes. BMJ Case Rep 2014; 2014:bcr2014204582.
34.
Hamad WB, Amar JB, Dhahri B, Baccar MA, Azzabi S, Aouina H, Bouacha H: Spontaneous chylothorax revealing a mediastinal and abdominal lymph node tuberculosis. Eur Respir J 2014; 44(suppl 58):P2648.
35.
Kim KJ, Park DW, Choi WS: Simultaneous chylothorax and chylous ascites due to tuberculosis. Infect Chemother 2014; 46: 50–53.
36.
Akthar M, Lardizabal A, Patrawalla AS, Emeh OK, Bolanowski PJ, Mangura B: Disseminated tuberculosis complicated by chylothorax. American Thoracic Society International Conference, May 15–20, 2015, abstract A3259. https://cms.psav.com/cPaper2015/myitinerary/session-11780.html?congress=ats2015.
37.
Kutlu O, Demirbas S, Sakin A: Chylothorax due to tuberculosis lymphadenitis. North Clin Istanb 2017; 3: 225–228.
38.
Del Cueto-Aguilera Á, Ibarra-Sifuentes H, Delgado-García G, Atilano A, Galarza-Delgado D: Chylothorax and chylous ascites due to Mycobacterium tuberculosis in an AIDS patient whose PCR tested negative. Pneumologia 2016; 65: 161–163.
39.
Amar JB, Zaibi H, Dahri B, Aouina H: Spontaneous chylothorax revealing a mediastinal and abdominal lymph node tuberculosis. Indian J Tuberc 2017; 64: 141–143.
40.
Duraikannan P, Saheer S, Balamugesh T, Christopher DJ: Rare cause of paradoxical worsening of pleural effusion in a patient with tuberculosis. Lung India 2017; 34: 167–169.
41.
Brandt M: Ein Beitrag zur Kasuistik der Ductus Thoracicus-Tuberkulose und des Chylothorax; Inaug Diss Heidelberg, Heidelberg, Universitäts-Buchdruckerei von J Horning, 1917.
42.
Kaplan M, Grumbach R, Grenier B: A case of right chylothorax during tuberculous primary infection (in French). Arch Fr Pediatr 1953; 10: 1060–1065.
43.
Mas Ramos A: Chylothorax and primary tuberculosis infection; brief summary of the clinical entity of chylothorax and case report (in Spanish). Rev Esp Tuberc 1954; 23: 123–130.
44.
Bujko K, Kruc S, Michalowicz R: Pleural chylothorax in a child with lymph node tuberculosis (in Polish). Pediatr Pol 1964; 39: 961–964.
45.
Leutke HJ, Sendel A: Chylothorax due to erosion of the thoracic duct in lymph node tuberculosis (in German). Med Welt 1966; 40: 2117–2120.
46.
Kovarik JL: Spontaneous right chylothorax with middle lobe syndrome. Report of a case. Dis Chest 1967; 52: 261–263.
47.
van der Heijden AH, Hamersma WB: Chylothorax as a rare complication in tuberculosis (in Dutch). Ned Tijdschr Geneeskd 1984; 128: 2260–2262.
48.
Li LY, Zhao QX, Luo WC: An analysis of 30 cases of chylothorax and chyloperitoneum (in Chinese). Zhonghua Nei Ke Za Zhi 1991; 30: 347–349, 382.
49.
El Hammoumi MM, Drissi G, Achir A, Benchekroun A, Kabiri EH, Benosman A: Spontaneous bilateral chylothorax revealing a mediastinal and abdominal lymph node tuberculosis (in French). Rev Pneumol Clin 2014; 70: 173–176.
50.
Menon RK, Aziah M, Kuppusamy I: Chylothorax secondary to tuberculosis. Med J Malaysia 1995; 50: 425–426.
51.
Anwar S, Rahman AKMM, Rahman ME, Mollah AH, Matin A, Bilqis L: Bilateral chylothorax due to disseminated tuberculosis and acute lymphoblastic leukemia in a young boy: a case report and literature review. Bangladesh J Child Health 2014; 38: 164–168.
52.
Naeem M, Sobani ZA, Zubairi A, Fatmi S, Khan JA: Constrictive pericarditis presenting as chylothorax. Singapore Med J 2011; 52: e187–e189.
53.
Summachiwakij S, Tungsubutra W, Koo-manachai P, Charoenratanakul S: Chylous ascites and chylothorax due to constrictive pericarditis in a patient infected with HIV: a case report. J Med Case Rep 2012; 6: 163.
54.
Büyükşirin M, Polat Gl, Usalan A, Aydoğdu Z: Chylothorax and sarcoidosis: case report. Tur Toraks Der 2011; 12: 117–119.
55.
Doerr CH, Allen MS, Nichols FC 3rd, Ryu JH: Etiology of chylothorax in 203 patients. Mayo Clin Proc 2005; 80: 867–870.
56.
Rajagopala S, Chandrasekharan S: Severe Mycobacterium tuberculosis-related immune reconstitution syndrome in an immunocompetent patient. Indian J Crit Care Med 2015; 19: 50–52.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.